Spruce Biosciences
Late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders, including congenital adrenal hyperplasia (CAH). Publicly traded on NASDAQ (SPRB).
Location
Daly City, California, USA
Founded
2016
Investors
2
Categories
therapeutics, biotech, endocrine-disorders, rare-disease, public-company
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| 5AM Ventures | Menlo Park, USA | biotech-focused | seedseries-a+1 | 8 |
| Abingworth | London, UK / Boston, USA | biotech-focused | seedseries-a+3 | 34 |